Skip to main content

Maria Buti Ferret

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Maria Buti Ferret

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Projects

Estudio de la eficacia de la lamivudina en hepatitis crónicas B y en trasplante hepático. Relación resistencia tratamiento y aparición mutantes VHB.

IP: Maria Buti Ferret
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 17086.77
Reference: 98/1330
Duration: 01/11/1998 - 01/11/1999

Related news

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

Related professionals

Guillem Pons Barcons

Guillem Pons Barcons

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Elisa Merino Peña

Elisa Merino Peña

Read more
Javier Sánchez López

Javier Sánchez López

Research technician
Research Group on Status Epilepticus and Acute Seizures
Read more
Pau Torrella Llauger

Pau Torrella Llauger

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.